Start Submission Become a Reviewer

Reading: Low rates of screening and treatment of chronic hepatitis B, C, D (HBV, HCV, HDV), and hepat...

Download

A- A+
Alt. Display

New and emerging priorities for global health

Low rates of screening and treatment of chronic hepatitis B, C, D (HBV, HCV, HDV), and hepatocellular carcinoma (HCC), associated barriers, and proposed solutions: results of a survey of physicians from all major provinces of Mongolia

Authors:

J. Estevez ,

Division of Gastroenterology and Hepatology at Stanford University, California, USA
X close

Y.A. Kim,

Division of Gastroenterology and Hepatology at Stanford University, California, USA
X close

A. Le,

Division of Gastroenterology and Hepatology at Stanford University, California, USA
X close

D. Israelski,

Center for Innovation In Global Health at Stanford University, California, USA
X close

O. Baatarkhuu,

Department of Infectious Diseases at Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia
X close

T. Sarantuya,

Internal Medicine Department at United Family Intermed Hospital, Ulaanbaatar, Mongolia
X close

S. Narantsetseg,

The Third State Central Hospital of Mongolia, Ulaanbaatar, Mongolia
X close

P. Nymadawa,

Public Health Branch, Mongolian Academy of Medical Sciences, Ulaanbaatar, Mongolia
X close

H. Le,

Division of Gastroenterology and Hepatology at Stanford University, California, USA
X close

M.F. Yuen,

Division of Gastroenterology and Hepatology at Queen Mary Hospital, Hong Kong
X close

G. Dusheiko,

Royal Free Hospital and University College London School of Medicine in London, United Kingdom
X close

M. Rizzetto,

Department of Gastroenterology at the University of Torino, Torino, Italy
X close

M.H. Nguyen

Division of Gastroenterology and Hepatology at Stanford University, California, USA
X close
How to Cite: Estevez, J., Kim, Y.A., Le, A., Israelski, D., Baatarkhuu, O., Sarantuya, T., Narantsetseg, S., Nymadawa, P., Le, H., Yuen, M.F., Dusheiko, G., Rizzetto, M. and Nguyen, M.H., 2016. Low rates of screening and treatment of chronic hepatitis B, C, D (HBV, HCV, HDV), and hepatocellular carcinoma (HCC), associated barriers, and proposed solutions: results of a survey of physicians from all major provinces of Mongolia. Annals of Global Health, 82(3), p.416. DOI: http://doi.org/10.1016/j.aogh.2016.04.159
3
Views
2
Downloads
Published on 20 Aug 2016.
Peer Reviewed

Downloads

  • PDF (EN)

    comments powered by Disqus